Filing Flows › Outset Medical (OM) › Guidance history
Outset Medical (OM) guidance history: what it guided and what it reported
Outset Medical gave guidance in 2 earnings releases on file since Aug 6, 2026.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $125M–$130M (Aug 6, 2026) → reaffirmed $125M–$130M (Nov 4, 2026) | — | to be reported | — |
Adjusted gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 40.0% (Aug 6, 2026) → reaffirmed 40.0% (Nov 4, 2026) | — | to be reported | — |
The latest quarter
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Questions
Does Outset Medical beat its guidance?
Outset Medical gave guidance in 2 earnings releases on file since Aug 6, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.